In The News
Upcoming Events
Patient Resources
Galil Medical Cryoablation Technology
 
 
OnDemand Media Center First and Second Generation Cryotherapy History
 
 

HomePress ReleasesAbout Galil MedicalInvestor RelationsContactsCustomer Support

   

CRYOABLATION TECHNOLOGY

Galil Medical Cryotherapy

History of Cryotherapy

First and Second Generation Cryotherapy History

Third Generation
Cryotherapy History

Cryobiology

Cryotherapy FAQ

Publications / References

New Product Development
for Cryosurgery

Next Generation of
Cryotherapy Products

Journal Articles

PROSTATE CANCER
CRYOTHERAPY

KIDNEY CANCER
CRYOTHERAPY

IMAGE-GUIDED
CRYOABLATION

CRYOABLATION
PRODUCTS

 

CRYOABLATION TECHNOLOGY

History of Cryotherapy

 

First and Second Generation Cryotherapy History

First Generation Cryosurgical Ablation
Liquid nitrogen cryogen was introduced into clinical practice in 1950 for the cryosurgical ablation of a variety of skin diseases. After the Second World War, liquid nitrogen became freely available. Allington used a cotton swab for treating various benign lesions but the method was insufficient for tumor treatment.

In 1961, the first cryosurgical equipment using liquid nitrogen was developed. Dr. Irving S. Cooper, an American neurosurgeon based in New York. He designed a liquid nitrogen probe with which he treated Parkinson's disease as well as inoperable brain tumors. His work led to increased interest in liquid nitrogen and helped to accelerate its acceptance as a standard for cryotherapy ablation. More general use of cryosurgery was also facilitated by the development of various devices suitable for ablation treatment in the doctor’s office.

While systems that employed liquid nitrogen were fairly simple and inexpensive, cryosurgery was performed by pouring liquid nitrogen via a funnel and did not provide accurate ablation. Large diameter probes subsequently replaced the funnels. Many new applications for cryosurgery were introduced during this time, including uterine, prostate, orthopedics, skin and sports injuries applications. Due to difficulties in controlling the size of the iceball and its freezing-thawing characteristics, these cryo treatments resulted in significant complications.

Second Generation Cryosurgery
Cryosurgery experienced a revival in the mid eighties with imaging-monitored cryosurgery and the first clinical reports of liver and prostate cancer treatments were published.

In the late 1980’s and throughout the 1990’s, second generation cryosurgery systems emerged, based on an advanced gas expansion method (Joule-Thomson principle). Although these systems demonstrated significant improvement in controlling the freezing process, they employed large diameter (3.2 mm) probes.

Joule-Thomson cycle cryoprobes had several advantages over systems that utilized liquid nitrogen. The refrigerant could be stored room temperature and the difficulties associated with supplying liquid nitrogen to the operating room disappeared. However, in order to avoid damage to adjacent healthy tissue, the probes were operated at only 25-50% of their maximum freezing power. The deliberately smaller iceballs generated by a few probes resulted in non-uniform isotherms.

   

     
 
 
 

© 2007 Galil Medical. All rights reserved.
Site Map | Disclaimers—Terms of Use | Glossary | More Information | HIPPA | Employees | Physicians
In The News | Upcoming Events | Patient Resources | OnDemand Media Center
Website Design by DDA Medical